Article info
PDFBasic and translational research
Extended report
Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
- Correspondence to Dr Timothy P LaBranche, Blueprint Medicines, 38 Sidney Street, Suite 200, Cambridge, MA 02139, USA; tlabranche{at}blueprintmedicines.com
Citation
Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
Publication history
- Received November 17, 2015
- Revised March 31, 2016
- Accepted April 29, 2016
- First published July 5, 2016.
Online issue publication
December 09, 2016
Article Versions
- Previous version (5 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/